By Caitlin Carmody, Communications Officer and Alyssa Figueroa, Campaigns Coordinator
Here at Breast Cancer Action, we’ve been working hard to make sure women have access to the evidence-based, patient-centered information they need to help make their healthcare decisions. We’ve also been advocating behind-the-scenes on important issues like mammography screening guidelines and breast cancer treatment development.
We’ve rounded up some of the most important information we put out over the last few months so you have it all in one place – from national op-eds to educational webinars to our analysis of new breast cancer studies.
If you have any questions, get in touch with us by calling us toll-free at 877-2-STOPBC or by email at email@example.com.
How the TPP Trade Deal Could Increase Risk of Dying of Breast Cancer
Our executive director Karuna Jaggar’s latest op-ed in EcoWatch explains how the Trans-Pacific Partnership (TPP) is a disastrous deal for both breast cancer patients and breast cancer prevention. Read why we’re telling our legislators: “Don’t trade away our health!”
Beyond “Awareness”: Metastatic Breast Cancer (Webinar)
Women don’t die of cancer that stays in the breast – they die when the disease spreads to other parts of the body – what’s called metastasis. For all the “awareness” of breast cancer these days, important facts about metastatic breast cancer often remain in the shadows. Tune into our webinar on Thursday, June 2nd to learn more about metastatic disease and what you can do. Even if you can’t attend at that time, register and we’ll send you a recording of the webinar.
Stop routine breast cancer screenings. Science has shown they don’t save lives
The Washington Post published an op-ed by our executive director Karuna Jaggar about the U.S. Preventive Services Task Force’s recently released draft of their new breast cancer screening recommendations. Read why these recommendations don’t go far enough in following the evidence about the shortcomings of mammography.
New Study Shows Half of Women With Dense Breasts Have Average to Low Cancer Risk.
Breast density is a hot topic in the news – and state legislatures – these days. What does breast density have to do with breast cancer risk, and what can women do with this information? Read the commentary from our executive director, Karuna Jaggar.
Comments to the United State Preventive Services Task Force re: Draft Guidelines for Mammography Screening
In May we submitted our official comments to the United State Preventive Services Task Force (USPSTF) about their new draft guidelines for mammography screening. Read what we have to say about these always-controversial guidelines.
Study Demonstrates Overtreatment Due to Misperceptions About Double Mastectomy
In recent years, many researchers and health writers have noted that more women are choosing to have their healthy breast removed at the time of a breast cancer diagnosis. A new study shows women may not be receiving unbiased, evidence-based information from their doctors about the risks and benefits of a contralateral prophylactic mastectomy (CPM).
Comments to the FDA on Patient-Focused Drug Development for Breast Cancer
Earlier this month, we submitted our official comments to the Food and Drug Administration (FDA) on patient-focused drug development for breast cancer. The agency that is charged with ensuring that drugs and devices are safe and effective should put patient interests – not corporate profits – first.
The Trials of Clinical Trials: The Importance of Including Everyone (Webinar)
All too often, clinical trial participants are overwhelmingly white and male. If not enough women and people of color are included in clinical trials, determining how diverse populations are affected by a new drug or device is impossible. Tune into this recording of our April webinar to learn about the importance and benefits of participant diversity in clinical trials, innovative methods to improve participation, and the advocacy work being done at the FDA.
EPA Report on Fracking and Drinking Water Only Skims the Surface
Earlier this month, the Environmental Protection Agency (EPA) released a long-awaited report about the impacts of fracking on drinking water. Our policy intern Aliza Kazmi digs into what the EPA’s report can – and can’t – tell us.
New Study Explores Impact of “Cavity Shave Margins” During Lumpectomy
A majority of women who are diagnosed with breast cancer—up to 90% by some estimates—are candidates for lumpectomy followed by radiation (which reduces the risk of recurrence in the same breast.). A new study explored the impact of removing more tissue all the way around the tumor site during the initial surgery, a practice called cavity shave margins (CSM).